Skip to Content
Merck
CN

Z628026

BRAND® UV cuvettes

semi-micro, chamber volume 1.5-3 mL

Synonym(s):

10 mm, Cuvettes, UV Polymer, UV-Cuvettes

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
SB.32
UNSPSC Code:
41121813
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

feature

Disposable plastic, Wavelength range: 230 to 900 nm, semi-micro

manufacturer/tradename

BRAND 759150

chamber volume

1.5-3 mL

window W × H

4.5 mm × 2.3 mm

General description

Ideally suited for concentration determinations through spectroscopy assays in water analysis, chemistry, and ife science applications. CERTIFIED LIFE SCIENCE QUALITY: Virgin raw materials, Manufactured under controlled room conditions, Intensive in-process controls, Visual inspections, Batch management, Final product inspection, Proven functionality.

Application

BRAND® UV cuvettes have been used in antigen adsorption and total protein content spectroscopy assays.

Features and Benefits

  • Compatible with acid, alkaline solutions, and the majority of polar solvents
  • Low price with significantly lower risk of contamination as compared to other quartz glass cuvettes
  • Standard 10 mm light path.

Other Notes

BR759150 (India)

Legal Information

BRAND is a registered trademark of BRAND GMBH + CO KG


Still not finding the right product?

Explore all of our products under BRAND® UV cuvettes




Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Sven Jirschitzka et al.
Archiv der Pharmazie, 356(6), e2300072-e2300072 (2023-03-29)
Pertuzumab (Perjeta®) is a monoclonal antibody approved for the treatment of HER2-positive breast cancer. Before treatment, the concentrate must be diluted to obtain the ready-to-use infusion solution. Data on the storage stabilities of these preparations are lacking but important for all
Kyle Lakatos et al.
Human vaccines & immunotherapeutics, 16(8), 1957-1968 (2020-01-30)
More effective rotavirus vaccines are essential for preventing extensive diarrheal morbidity and mortality in children under five years of age in low-resource regions. Nonreplicating rotavirus vaccines (NRRV) administered parenterally provide an alternate vaccination method to the current licensed oral vaccine.



Global Trade Item Number

SKUGTIN
Z628026-100EA04061831868852